Asthma, airway biology, and nasal disorders in AJRCCM 2002.
about
The Saudi Initiative for Asthma.Drugs in clinical development for chronic obstructive pulmonary disease.Emerging drugs for the treatment of chronic obstructive pulmonary disease.Clinical safety of long-acting beta2-agonist and inhaled corticosteroid combination therapy in COPD.The potential for genetically altered microglia to influence glioma treatment.
P2860
Asthma, airway biology, and nasal disorders in AJRCCM 2002.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Asthma, airway biology, and nasal disorders in AJRCCM 2002.
@ast
Asthma, airway biology, and nasal disorders in AJRCCM 2002.
@en
type
label
Asthma, airway biology, and nasal disorders in AJRCCM 2002.
@ast
Asthma, airway biology, and nasal disorders in AJRCCM 2002.
@en
prefLabel
Asthma, airway biology, and nasal disorders in AJRCCM 2002.
@ast
Asthma, airway biology, and nasal disorders in AJRCCM 2002.
@en
P2860
P356
P1476
Asthma, airway biology, and nasal disorders in AJRCCM 2002.
@en
P2093
Martin J Tobin
P2860
P304
P356
10.1164/RCCM.2212007
P407
P577
2003-02-01T00:00:00Z